Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

When Will it be Safe to Jump Back into the Gold and Silver Pool?

Once again the DSI (Daily Sentiment Indicator) made an accurate call on a major top in gold and silver. The DSI reached nosebleed territory for gold about four weeks ago suggesting the metals were nearing shoal waters. Silver and platinum got stupid a week ago and I su...
Streetwise Reports | September 13, 2019 |

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...
Mario Hose | September 18, 2020 |

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson | October 8, 2020 |

Novamind’s Trial Site for Merck Another Example Of Its Leadership in Mental Health

Novamind’s clinics and clinical research capabilities are already well established to bring alternative mental health therapies, including psychedelic medicine, to market. One of the world’s largest pharmaceutical companies has selected ...
Featured Submission | March 24, 2021 |

THE BATTLE BETWEEN SAFE HAVENS AND RISK ON CONTINUES

With all the fear around the world, it is fascinating to watch the battle that is underway between risk-on and risk-off assets. Chris Vermeulen joins Cory Fleck to share the way he is trading these markets and what he thinks will cause a breakout in either risk-on or risk-off....
Chris Vermeulen | January 7, 2020 |

Safe Haven Surge Has Only Just Begun for Silver and Silver Miners

While silver has thus far lagged the gains of gold, a number of trends underlying the metal should pave the way for a new leg up very soon, according to McAlinden Research Partners. Summary: Amid the precious metals rally that was set off by the rapid spread of cor...
Streetwise Reports | March 4, 2020 |

Buzz on the Bullboards: Markets struggle in Q1 2023

Despite a solid start to the year, markets on Bay Street and Wall Street have struggled since fresh calendars went up. This week, Canada’s top banks have been pointing to economic pain ahead with higher loan loss provisions and a fall in quarterly prof...
Jonathon Brown | March 2, 2023 |

Calibre Has Some Safety in the Storm

Last week provided a glimpse into the future of the stock market. Only a glimpse. It is going to get a whole lot worse. On January 1, I said in an article I titled Beware the Stock Market , " As the Everything Bubble pops, the financial system will destroy most inves...
Streetwise Reports | March 2, 2020 |

The Case for Buying Precious Metals

Maurice Jackson of Proven and Probable speaks with Andy Schectman, president of Miles Franklin Precious Metals Investments, about the rationale for buying precious metals and the best values at this time. Maurice Jackson: Joining us for a conversation is And...
Streetwise Reports | February 6, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...